Pearls and pitfalls in nonalcoholic fatty liver disease: tricky results are common

por Wentworth, Brian J., Caldwell, Stephen H.
Publicado 2021

A Case of Retinal Tear Associated with Use of Sorafenib

por Gaertner, Kelly M., Caldwell, Stephen H., Rahma, Osama E.
Publicado 2014

Thrombocytopenia and Procedural Prophylaxis in the Era of Thrombopoietin Receptor Agonists

por Nilles, Kathy M., Caldwell, Stephen H., Flamm, Steven L.
Publicado 2019

Advanced non-alcoholic steatohepatitis cirrhosis: A high-risk population for pre-liver transplant portal vein thrombosis

por Stine, Jonathan G, Argo, Curtis K, Pelletier, Shawn J, Maluf, Daniel G, Caldwell, Stephen H, Northup, Patrick G
Publicado 2017

Serial MRI Imaging Reveals Minimal Impact of Ketogenic Diet on Established Liver Tumor Growth

por Byrne, Frances L., Hargett, Stefan R., Lahiri, Sujoy, Roy, R. Jack, Berr, Stuart S., Caldwell, Stephen H., Hoehn, Kyle L.
Publicado 2018

Increased risk of venous thromboembolism in hospitalized patients with cirrhosis due to non-alcoholic steatohepatitis

por Stine, Jonathan G., Niccum, Blake A., Zimmet, Alex N., Intagliata, Nicolas, Caldwell, Stephen H., Argo, Curtis K., Northup, Patrick G.
Publicado 2018

Dietary sugar intake increases liver tumor incidence in female mice

por Healy, Marin E., Lahiri, Sujoy, Hargett, Stefan R., Chow, Jenny D.Y., Byrne, Frances L., Breen, David S., Kenwood, Brandon M., Taddeo, Evan P., Lackner, Carolin, Caldwell, Stephen H., Hoehn, Kyle L.
Publicado 2016

Distinct Roles for Intracellular and Extracellular Lipids in Hepatitis C Virus Infection

por Narayanan, Sowmya, Nieh, Albert H., Kenwood, Brandon M., Davis, Christine A., Tosello-Trampont, Annie-Carole, Elich, Tedd D., Breazeale, Steven D., Ward, Eric, Anderson, Richard J., Caldwell, Stephen H., Hoehn, Kyle L., Hahn, Young S.
Publicado 2016

The ASK1 inhibitor selonsertib in patients with nonalcoholic steatohepatitis: A randomized, phase 2 trial

por Loomba, Rohit, Lawitz, Eric, Mantry, Parvez S., Jayakumar, Saumya, Caldwell, Stephen H., Arnold, Hays, Diehl, Anna Mae, Djedjos, C. Stephen, Han, Ling, Myers, Robert P., Subramanian, G. Mani, McHutchison, John G., Goodman, Zachary D., Afdhal, Nezam H., Charlton, Michael R.
Publicado 2017

Inhibition of hepatic lipogenesis enhances liver tumorigenesis by increasing antioxidant defence and promoting cell survival

por Nelson, Marin E., Lahiri, Sujoy, Chow, Jenny D. Y., Byrne, Frances L., Hargett, Stefan R., Breen, David S., Olzomer, Ellen M., Wu, Lindsay E., Cooney, Gregory J., Turner, Nigel, James, David E., Slack-Davis, Jill K., Lackner, Carolin, Caldwell, Stephen H., Hoehn, Kyle L.
Publicado 2017

Improvements of Fibrosis and Disease Activity Are Associated With Improvement of Patient‐Reported Outcomes in Patients With Advanced Fibrosis Due to Nonalcoholic Steatohepatitis

por Younossi, Zobair M., Stepanova, Maria, Noureddin, Mazen, Kowdley, Kris V., Strasser, Simone I., Kohli, Anita, Ruane, Peter, Shiffman, Mitchell L., Sheikh, Aasim, Gunn, Nadege, Caldwell, Stephen H., Huss, Ryan S., Myers, Robert P., Wai‐Sun Wong, Vincent, Alkhouri, Naim, Goodman, Zachary, Loomba, Rohit
Publicado 2021

Genetic inhibition of hepatic acetyl-CoA carboxylase activity increases liver fat and alters global protein acetylation()

por Chow, Jenny D.Y., Lawrence, Robert T., Healy, Marin E., Dominy, John E., Liao, Jason A., Breen, David S., Byrne, Frances L., Kenwood, Brandon M., Lackner, Carolin, Okutsu, Saeko, Mas, Valeria R., Caldwell, Stephen H., Tomsig, Jose L., Cooney, Gregory J., Puigserver, Pere B., Turner, Nigel, James, David E., Villén, Judit, Hoehn, Kyle L.
Publicado 2014